TTK Healthcare Limited (NSE:TTKHLTCARE)
1,125.20
-18.10 (-1.58%)
Aug 14, 2025, 3:29 PM IST
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.26B INR in the quarter ending June 30, 2025, with 8.91% growth. This brings the company's revenue in the last twelve months to 8.20B, up 8.10% year-over-year. In the fiscal year ending March 31, 2025, TTK Healthcare had annual revenue of 8.01B with 6.47% growth.
Revenue (ttm)
8.20B
Revenue Growth
+8.10%
P/S Ratio
1.94
Revenue / Employee
6.12M
Employees
1,339
Market Cap
15.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
Mar 31, 2021 | 4.76B | -1.70B | -26.28% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |